Angina Industry Drivers, Size & Growth Insights 2024

Angina Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

 

Market Size –

The angina market size has grown strongly in recent years. It will grow from $10.11 billion in 2023 to $10.71 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%.  The growth in the historic period can be attributed to increased prevalence of coronary heart disease, increased use of vasodilators, increased prevalence of myocardial ischemia, improved diagnostic capabilities, increased use of imaging techniques.

 

The angina market size is expected to see strong growth in the next few years. It will grow to $13.61 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%.  The growth in the forecast period can be attributed to increasing prevalence of chronic angina pectoris, rising drug approvals and clinical research, increasing demand for retail pharmacies, growing awareness of cardiovascular health, growing demand for medications. Major trends in the forecast period include technological advancements in early diagnosis, advancements in angioplasty and stenting, new gene therapy approaches, demand for coronary stents, advancements in coronary artery disease treatment.

 

Order your report now for swift delivery @

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

 

Scope Of Angina Market

The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

 

Angina Market Overview

Market Drivers –

The rising cases of coronary artery diseases are expected to propel the growth of the angina market going forward. Coronary artery disease (CAD), also known as coronary heart disease (CHD) or ischemic heart disease (IHD), is a condition characterized by the narrowing or blockage of the coronary arteries, which supply blood, oxygen, and nutrients to the heart muscle. The rising cases of coronary artery disease (CAD) are due to lifestyle changes and environmental and genetic factors. Angina plays a critical role in identifying and understanding the prevalence of coronary artery disease. Its presence prompts medical evaluation and diagnosis, helps stratify risk, guides treatment decisions, and informs public health strategies. For instance, in January 2023, according to the American Heart Association, from 2021 to 2022, the number of adults living with Coronary artery disease (CAD) in the U.S. rose from 18.2 million to approximately 19.3 million. Therefore, rising cases of coronary artery diseases drive the angina market.

 

Market Trends –

Major companies operating in the angina market are developing innovative drugs such as metoprolol tartrate tablets to provide more effective and targeted treatments for patients who have coronary artery disease (CAD) and related conditions. Metoprolol tartrate tablets are a form of medication commonly used to treat various cardiovascular conditions, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, received final approval from the United States Food and Drug Administration (US-FDA) to manufacture and market its generic version of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol is a beta blocker used to treat various cardiovascular conditions, including high blood pressure (hypertension) and chest pain (angina), and to improve survival after a heart attack.

 

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

 

Get an inside scoop of the angina market, Request now for Sample Report @

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

 

Regional Insights –

North America was the largest region in the angina market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

 

Key Companies –

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG , Bristol-Myers Squibb Company , AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company , Gilead Sciences Inc. , Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals , Juventas Therapeutics , Milestone Pharmaceuticals

 

Table of Contents

1. Executive Summary
2. Angina Market Report Structure
3. Angina Market Trends And Strategies
4. Angina Market – Macro Economic Scenario
5. Angina Market Size And Growth

…..

27. Angina Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

 

List Of Tables:

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Angina Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Angina Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Angina Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

……………

Table 75: Pfizer Inc. Financial Performance

Table 76: Johnson & Johnson Financial Performance

Table 77: F. Hoffmann-La Roche AG Financial Performance

Table 78: Merck & Co Inc. Financial Performance

Table 79: Bayer AG Financial Performance

 

Read Related Reports:

https://goodprnews.com/collateralized-loan-obligation-market-growth/

https://topprnews.com/cruise-safari-market-trends/

 

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

 

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model